M&G Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

M&G Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,824	Closed	-$1.66K	–	473
2022 Q3	$1.66K	Buy	+26,824	New	+$1.87M	0.01%	259
2021 Q1	–	Sell	-31,790	Closed	-$2.32K	–	498
2020 Q4	$2.32K	Sell	31,790 -337	-1%	-$25.1K	0.01%	261
2020 Q3	$2.51M	Buy	+32,127	New	+$2.21M	0.03%	255

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

M&G Investment Management's HZNP Position: Q4 2022 in Review

M&G Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 26,824 shares — an estimated $1.66K sold.

M&G Investment Management first reported a position in HZNP in Q3 2020 and held it in 3 quarters. The position peaked at $2.51M in Q3 2020. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

M&G Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
M&G Investment Management sold 26,824 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.66K.
M&G Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 3 quarters.
M&G Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.51M in Q3 2020.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on M&G Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.